{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:29:21Z","timestamp":1795148961542,"version":"4.10.3"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>With the increasing incidence of diabetes, diabetic foot ulcer(DFU) has become one of the most common and serious complications in people with diabetes. DFU is associated with significant morbidity and mortality, and can also result in significant economic, social and public health burdens. Due to peripheral neuropathy, peripheral vascular disease, hyperglycemic environment, inflammatory disorders and other factors, the healing of DFU is impaired or delayed, resulting in the formation of diabetic chronic refractory ulcer. Because of these pathological abnormalities in DFU, it may be difficult to promote wound healing with conventional therapies or antibiotics, whereas platelet-rich plasma(PRP) can promote wound healing by releasing various bioactive molecules stored in platelets, making it more promising than traditional antibiotics. Therefore, the purpose of this systematic review is to summarize and analyze the efficacy of PRP in the treatment of DFU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search was undertaken in PubMed, CNKI, EMB-ASE, the Cochrane Library, the WanFang Database and the WeiPu Database by computer. Included controlled studies evaluating the efficacy of PRP in the treatment of diabetic foot ulcers. The data extraction and assessment are on the basis of PRISMA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty studies were evaluated, and nineteen measures for the evaluation of the efficacy of PRP in DFU treatment were introduced by eliminating relevant duplicate measures. The efficacy measures that were repeated in various studies mainly included the rate of complete ulcer healing, the percentage of ulcer area reduction, the time required for ulcer healing, wound complications (including infection rate, amputation rate, and degree of amputation), the rate of ulcer recurrence, and the cost and duration of hospitalization for DFU, as well as subsequent survival and quality of life scores. One of the most important indicators were healing rate, ulcer area reduction and healing time. The meta-analysis found that PRP was significantly improve the healing rate(OR = 4.37, 95% CI 3.02-6.33, P &amp;lt; 0.001) and shorten the healing time(MD = -3.21, 95% CI -3.83 to -2.59,P &amp;lt; 0.001)of patients with DFU when compared to the conventional treatment, but there was no significant difference in reducing the of ulcer area(MD = 5.67, 95% CI -0.77 to 12.11,P =0.08&amp;gt;0.05 ).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The application of PRP to DFU can improve ulcer healing rate and shorten ulcer healing time, but more clinical data are needed to clarify some efficacy measures. At the same time, a standardized preparation process for PRP is essential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2023.1256081","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T06:29:16Z","timestamp":1702880956000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":69,"title":["Platelet-rich plasma for the treatment of diabetic foot ulcer: a systematic review"],"prefix":"10.3389","volume":"14","author":[{"given":"Hong","family":"OuYang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B2","doi-asserted-by":"publisher","first-page":"109118","DOI":"10.1016\/j.diabres.2021.109118","article-title":"IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021","volume":"183","author":"Ogurtsova","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"New Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/wrr.12391","article-title":"WHS guidelines update: diabetic foot ulcer treatment guidelines","volume":"24","author":"Lavery","year":"2016","journal-title":"Wound Repair Regen"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009212","article-title":"Three-week topical treatment with placenta-derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer: a case report","volume":"96","author":"Zeng","year":"2017","journal-title":"Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000002686","article-title":"The role of pressure offloading on diabetic foot ulcer healing and prevention of recurrence","volume":"138","author":"Bus","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2019.10.009","article-title":"Assessment of the risk factors of multidrug-resistant organism infection in adults with type 1 or type 2 diabetes and diabetic foot ulcer","author":"Dai","year":"2019","journal-title":"Can J Diabetes"},{"key":"B8","article-title":"Diabetic foot ulcer","volume-title":"The Chinese Medical Association","author":"Oliver","year":"2022"},{"key":"B9","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3390\/ijms17060917","article-title":"Neuropathy and diabetic foot syndrome","volume":"17","author":"Volmer-Thole","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2016.1231932","article-title":"Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis\u2020","volume":"49","author":"Zhang","year":"2017","journal-title":"Ann Med"},{"key":"B11","first-page":"92","article-title":"Chinese Guidelines for prevention and treatment of diabetic foot (2019 edition)","volume":"11","year":"2019","journal-title":"Chin J Diab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e04469","article-title":"Prevalence and factors associated with lower limb amputation in individuals with type II diabetes mellitus in a referral hospital in Fortaleza, Cear\u00e1, Brazil: A hospital-based cross-sectional study","volume":"6","author":"Alves","year":"2020","journal-title":"Heliyon"},{"key":"B13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12902-019-0353-8","article-title":"Incidence and determinants of diabetes-related lower limb amputations in Ghana, 2010-2015- a retrospective cohort study","volume":"19","author":"Sarfo-Kantanka","year":"2019","journal-title":"BMCEndocr Disord"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-11-18","article-title":"A retrospective analysis of amputation rates in diabetic patients: can lower extremity amputations be further prevented","volume":"11","author":"Alvarsson","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"101909","DOI":"10.1016\/j.foot.2022.101909","article-title":"Health economics of diabetic foot ulcer and recent trends to accelerate treatment","volume":"52","author":"Jodheea-Jutton","year":"2022","journal-title":"Foot"},{"key":"B16","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-020-04699-9","article-title":"Wound treatment in diabetes patients and diabetic foot ulcers","volume":"71","author":"Riedel","year":"2020","journal-title":"Hautarzt"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0200","article-title":"Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade","volume":"35","author":"Morbach","year":"2012","journal-title":"Diabetes Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2180-13-47","article-title":"Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity","volume":"13","author":"Drago","year":"2013","journal-title":"BMC Microbiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.transci.2009.05.006","article-title":"Autologous platelets and leukocytes can improve healing of infected high-energy soft tissue injury","volume":"41","author":"Cieslik-Bielecka","year":"2009","journal-title":"Transfus Apher Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40141-013-0039-5","article-title":"PRP: review of the current evidence for musculoskeletal conditions","volume":"2","author":"Malanga","year":"2014","journal-title":"Curr Phys Med Rehab Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5999\/aps.2013.40.5.530","article-title":"Platelet-rich plasma: quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups","volume":"40","author":"Lee","year":"2013","journal-title":"ArchPlast Surg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/01.prs.0000239606.92676.cf","article-title":"Platelet-rich plasma: A review of biology and applications in plastic surgery","volume":"118","author":"Eppley","year":"2006","journal-title":"Plast Reconstr Surg"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2008.11.009","article-title":"Classifification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fifibrin (L-PRF)","volume":"27","author":"Dohan Ehrenfest","year":"2009","journal-title":"Trends Biotechnol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2020.10.003","article-title":"Autologous platelet-rich plasma for diabetic foot ulcer","author":"Shao","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/wrr.12690","article-title":"Platelet-rich plasma for the treatment of diabetic foot ulcers: A meta-analysis","volume":"27","author":"Pino-Sede\u00f1o","year":"2019","journal-title":"Wound Repair Regener"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107611","article-title":"Autologous platelet-rich plasma treatment for patients with diabetic foot ulcers: a meta-analysis of randomized studies","volume":"34","author":"Dai","year":"2020","journal-title":"J Diabetes Complications"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.13858","article-title":"Effect of platelet-rich plasma vs standard management for the treatment of diabetic foot ulcer wounds: A meta-analysis","volume":"20","author":"Gong","year":"2023","journal-title":"Int Wound J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000006281","article-title":"The efficacy of platelet-rich plasma dressing for chronic nonhealing ulcers: A meta-analysis of 15 randomized controlled trials","volume":"144","author":"Xia","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"B30","doi-asserted-by":"publisher","first-page":"15347346221094424","DOI":"10.1177\/15347346221094424","article-title":"PRP versus standard of care for venous leg ulcers: A systematic review and meta-analysis of prospective comparative studies","volume":"14","author":"Yammine","year":"2022","journal-title":"Int J Low Extrem Wounds"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.01.030","article-title":"The effectiveness and safety of platelet-rich plasma for chronic wounds: A systematic review and meta-analysis","volume":"96","author":"Qu","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"B32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7547\/19-149","article-title":"Efficacy of intra-lesional platelet rich plasma in diabetic foot ulcer","volume":"111","author":"Gupta","year":"2021","journal-title":"J Am Podiatr Med Assoc"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.13640","article-title":"Histological analysis of fat grafting with platelet-rich plasma for diabetic foot ulcers-A randomised controlled trial","volume":"19","author":"Nolan","year":"2022","journal-title":"Int Wound J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2016.04.023","article-title":"Platelet rich plasma for the treatment of clean diabetic foot ulcers","volume":"38","author":"Ahmed","year":"2016","journal-title":"Ann Vasc Surg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.03.005","article-title":"Evaluation of the efficacy of platelet-rich plasma on healing of clean diabetic foot ulcers: A randomized clinical trial in Tehran, Iran","volume":"15","author":"Alamdari","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2017.26.12.784","article-title":"Management of chronic diabetic foot ulcers using platelet-rich plasma","volume":"26","author":"Babaei","year":"2017","journal-title":"J Wound Care"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2018.27.9.550","article-title":"Role of platelet-rich plasma in healing diabetic foot ulcers: a prospective study","volume":"27","author":"Singh","year":"2018","journal-title":"J Wound Care"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-019-05316-0","article-title":"Randomized controlled trial on autologous platelet-rich plasma versus saline dressing in treatment of non-healing diabetic foot ulcers","volume":"44","author":"Elsaid","year":"2020","journal-title":"World J Surg"},{"key":"B39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.25270\/wnds\/2022.3642","article-title":"Autologous platelet-rich plasma vs conventional dressing in the management of chronic diabetic foot ulcers","volume":"33","author":"Orban","year":"2022","journal-title":"Wounds"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2021.10.061","article-title":"Autologous platelet rich plasma promotes the healing of non-ischemic diabetic foot ulcers. A randomized controlled trial","volume":"82","author":"Hossam","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2019.09.069","article-title":"Autologous platelet-rich gel for the treatment of diabetic sinus tract wounds: A clinical study","volume":"247","author":"Xie","year":"2020","journal-title":"J Surg Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2019.28.10.658","article-title":"Effectiveness of autologous platelet-rich plasma gel in the treatment of hard-to-heal leg ulcers: a randomised control trial","volume":"28","author":"Rainys","year":"2019","journal-title":"J Wound Care"},{"key":"B43","first-page":"68","article-title":"A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers","volume":"52","author":"Driver","year":"2006","journal-title":"Ostomy Wound Manage"},{"key":"B44","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/wrr.12294","article-title":"Autologous platelet-rich gel for treatment of diabetic chronic refractory cutaneous ulcers: A prospective, randomized clinical trial","volume":"23","author":"Li","year":"2015","journal-title":"Wound Repair Regener"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1177\/0963689720931428","article-title":"Comparison of allogeneic platelet-rich plasma with autologous platelet-rich plasma for the treatment of diabetic lower extremity ulcers","volume":"29","author":"He","year":"2020","journal-title":"Cell Transplant"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28292","article-title":"Effectiveness of injected platelet-rich plasma in the treatment of diabetic foot ulcer diseasen","volume":"14","author":"Ullah","year":"2022","journal-title":"Cureus"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2010.07.003","article-title":"Increased survival of free fat grafts with platelet-rich plasma in rabbits","volume":"63","author":"Pires Fraga","year":"2010","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-481X.2011.00797.x","article-title":"Platelet-rich plasma versus platelet-poor plasma in the management of chronic diabetic foot ulcers: a comparative study","volume":"8","author":"Setta","year":"2011","journal-title":"Int Wound J"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.13433","article-title":"Fat grafting and platelet-rich plasma for the treatment of diabetic foot ulcers: A feasibility-randomised controlled trial","volume":"17","author":"Smith","year":"2020","journal-title":"Int Wound J"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4081\/cp.2013.e9","article-title":"Comparative study of different treatment options of grade III and IV diabetic foot ulcers to reduce the incidence of amputations","volume":"3","author":"Khandelwal","year":"2013","journal-title":"Clinics Pract"},{"key":"B51","doi-asserted-by":"publisher","first-page":"108282","DOI":"10.1016\/j.intimp.2021.108282","article-title":"Improved wound healing of diabetic foot ulcers using human placenta-derived mesenchymal stem cells in gelatin electrospun nanofibrous scaffolds plus a platelet-rich plasma gel: A randomized clinical trial","volume":"101","author":"Meamar","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/SAP.0b013e3181b0273c","article-title":"Platelet rich plasma (PRP) promotes survival of fat-grafts in rats","volume":"65","author":"Nakamura","year":"2010","journal-title":"Ann Plast Surg"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1.e1","DOI":"10.1016\/j.jaad.2013.06.055","article-title":"Diabetic foot ulcers: part I. Pathophysiology and prevention","volume":"70","author":"Alavi","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B54","first-page":"92","article-title":"Chinese guidelines for the prevention and treatment of diabetic foot (2019 edition)(I)","volume":"11","year":"2019","journal-title":"Chin J Diab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.25270\/wnds\/2022.175177","article-title":"Diabetic foot ulcer: treatment challenges","volume":"34","author":"Bolton","year":"2022","journal-title":"Wounds"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1177\/1534734612447617","article-title":"Clinical\u2013pathological characterization of diabetic foot infections: grading the severity of osteomyelitis","volume":"11","author":"Arag\u00f3n-S\u00e1nchez","year":"2012","journal-title":"Int J Low Extrem Wounds"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i1.37","article-title":"Literature review on the management of diabetic foot ulcer","volume":"6","author":"Yazdanpanah","year":"2015","journal-title":"World J Diab"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1715237","article-title":"Evaluation and management of lower-extremity ulcers","volume":"378","author":"Singer","year":"2018","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtv.2016.06.005","article-title":"Genetic and molecular basis of diabetic foot ulcers: clinical review","volume":"25","author":"Jhamb","year":"2016","journal-title":"J Tissue Viabil"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1590\/S0102-86502009000400006","article-title":"Effects of platelet-rich plasma gel on skin healing in surgical wound in horses","volume":"24","author":"DeRossi","year":"2009","journal-title":"Acta Cir Bras"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0b013e3182597ce6","article-title":"Effect of intraoperative platelet-rich plasma and fibrin glue application on skin flap survival","volume":"23","author":"Findikcioglu","year":"2012","journal-title":"J Craniofac Surg"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12850","article-title":"Autologous platelet-rich gel treatment for diabetic chronic cutaneous ulcers: A meta-analysis of randomized controlled trials","volume":"11","author":"Li","year":"2019","journal-title":"J Diabetes"},{"key":"B63","doi-asserted-by":"publisher","first-page":"S0890-5096(23)00332-1","DOI":"10.1016\/j.avsg.2023.05.045","article-title":"Efficacy of platelet-rich plasma in the treatment of diabetic foot ulcers: A systematic review and meta-analysis","volume":"22","author":"Peng","year":"2023","journal-title":"Ann Vasc Surg"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2013.01.016","article-title":"The effect of platelet rich plasma on angiogenesis in ischemic flaps in VEGFR2-luc mice","volume":"34","author":"S\u00f6nmez","year":"2013","journal-title":"Biomater"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2011.05.051","article-title":"PRP&F\/P MPs improved survival of dorsal paired pedicle skin flaps in rats","volume":"170","author":"Takikawa","year":"2011","journal-title":"J Surg Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e3182450ac9","article-title":"Subcutaneous injections of platelet-rich plasma into skin flaps modulate proangiogenic gene expression and improve sur vival rates","volume":"129","author":"Li","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2018.12.039","article-title":"Does non-activated platelet-rich plasma (PRP) enhance fat graft outcome? An assessment with 3D CT-scan in mice","volume":"72","author":"Atashi","year":"2019","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.13956","article-title":"A meta-analysis on the efficacy of vacuum sealing drainage combined with autologous platelet-rich plasma in the treatment of Grade 2 and Grade 3 diabetic foot ulcers","volume":"20","author":"Yin","year":"2022","journal-title":"Int Wound J"},{"key":"B69","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1152\/physrev.00067.2017","article-title":"Wound healing: A cellular perspective","volume":"99","author":"Rodrigues","year":"2019","journal-title":"Physiol Rev"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3390\/ijms18051068","article-title":"The role of phytochemicals in the inflammatory phase of wound healing","volume":"18","author":"Shah","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200223","article-title":"Wound healing: cellular mechanisms and pathological outcomes","volume":"10","author":"Wilkinson","year":"2020","journal-title":"Open Biol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2020.29.11.658","article-title":"Assessment of diabetic foot ulcers based on pictorial material: an interobserver study","volume":"29","author":"J\u00f8rgensen","year":"2020","journal-title":"J Wound Care"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/385641","article-title":"Current aspects in the pathophysiology and treatment of chronic wounds in diabetes mellitus","volume":"2013","author":"Tsourdi","year":"2013","journal-title":"BioMed Res Int"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/ph13040060","article-title":"The treatment of impaired wound healing in diabetes: looking among old drugs","volume":"13","author":"Spampinato","year":"2020","journal-title":"Pharm (Basel)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol Rev"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.2450\/2018.0111-18","article-title":"Effificacy of platelet-rich plasma as conservative treatment in orthopaedics: a systematic review and meta-analysis","volume":"16","author":"Franchini","year":"2018","journal-title":"Blood Transfus"},{"key":"B77","doi-asserted-by":"crossref","DOI":"10.1111\/j.1751-2824.2007.00085.x","article-title":"Platelet-rich plasma (PRP) and platelet derivatives for topical therapy. What is true from the biologic view point","volume":"2","author":"Borzini","year":"2007","journal-title":"ISBT Sci Ser"},{"key":"B78","doi-asserted-by":"publisher","first-page":"CD008548","DOI":"10.1002\/14651858.CD008548.pub2","article-title":"Growth factors for treating diabetic foot ulcers","volume":"2015","author":"Marti-Carvajal","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00290","article-title":"The inflfluence of platelet-derived products on angiogenesis and tissue repair: a concise update","volume":"6","author":"Mart\u00ednez","year":"2015","journal-title":"Front Physiol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0b013e3181f43f0a","article-title":"Cell-based cytokine therapy for skin rejuvenation","volume":"21","author":"Ueda","year":"2010","journal-title":"J Craniofac Surg"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.12500","article-title":"The use of growth factors, CD34(+) cells and fibrin for the management of chronic venous ulcers","volume":"13","author":"Romano","year":"2016","journal-title":"Int Wound J"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000002094","article-title":"Collagen and fractionated platelet-rich plasma scaffold for dermal regeneration","volume":"137","author":"Houdek","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2012.03668.x","article-title":"Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent\/ detergent-treated PLT lysate biomaterials against wound bacteria","volume":"53","author":"Burnouf","year":"2013","journal-title":"Transfusion"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2014.06.003","article-title":"Platelet-rich plasma affects bacterial growth in vitro","volume":"16","author":"Mariani","year":"2014","journal-title":"Cytotherapy"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.7.2551-2557.2004","article-title":"Beneficial influence of platelets on antibiotic efficacy in an in vitro model of Staphylococcus aureus-induced endocarditis","volume":"48","author":"Mercier","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1256081\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T06:29:20Z","timestamp":1702880960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1256081\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,18]]},"references-count":85,"alternative-id":["10.3389\/fendo.2023.1256081"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1256081","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2023.1256081.s001","asserted-by":"subject"}]},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,18]]},"article-number":"1256081"}}